Home / Guides / Ro alternatives

Know the yearly number before you choose.

Ro weight loss alternatives: 3 options, compared on price and care

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated

NexLife publishes this guide and is one of the programs in it. Every program, ours included, faces the same tests, and every price links to its source.

Ro prescribes brand-name Zepbound at $448 to $598 a month and Wegovy at $298 to $548, its $149 monthly membership included (checked November 1, 2026). At NexLife, compounded tirzepatide is $139 a month on the 12-month plan or $169 month to month, at every dose, with no membership fee.

$139/mo on 12 months, every dosePrice Match Guarantee†

  • Ro, Zepbound: $448 to $598 a month, membership included
  • Ro, first year of Zepbound: about $7,315
  • NexLife, compounded: $1,668 a year on the 12-month plan

Ro at a glance

Medication
Brand-name Zepbound and Wegovy, pen and pill
Zepbound
$448 to $598 a month, membership included
Wegovy
$298 to $548 a month, membership included
Membership
$149 a month, or $74 if you prepay a year
Insurance
Helps check your coverage

Not sure which costs less for you? Call or text (949) 818-8000, 24/7.

Check my eligibility

4.8 out of 5 on Trustpilot · LegitScript certified

About 3 minutes of health questions. No insurance needed. Compounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.

The numbers

How much does a year of Ro cost vs. LillyDirect and NexLife?

About $7,315 for a first year of Zepbound on Ro’s monthly membership, or $6,564 with the membership prepaid, on a typical dose ladder (checked November 1, 2026). LillyDirect, with no membership, comes to $5,637. Compounded tirzepatide at NexLife is $1,668 a year on the 12-month plan, or $2,028 month to month.

A first year of tirzepatide, four ways
RouteFirst yearHow we got there
Ro, monthly membership$7,31513 four-week fills of Zepbound ($5,637) plus $1,678 of membership ($39 the first month, then $149); from 7.5 mg
Ro, membership prepaid for a year$6,564Zepbound’s $5,637 plus $927 of membership ($39 the first month, then $888 for a prepaid year)
LillyDirect, no membership$5,637$299, $399, then $449 for each four-week fill, 13 a year ($449, from 7.5 mg, needs a refill within 45 days; otherwise $499–$699); prescriber visits extra
NexLife, compounded$1,668$139 a month on a 12-month plan, at every dose; $2,028 month to month ($169 a month) Pay less elsewhere? Matched†

Assumes a typical dose ladder: 2.5 mg, then 5 mg, then 7.5 mg or more from month 3. Ro’s prices include its $149 monthly membership ($74 a month prepaid). Checked November 1, 2026. Compounded tirzepatide isn’t FDA-approved; Zepbound is.

NexLife Price Match Guarantee†. Already on compounded tirzepatide or semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • Ro weight loss alternatives: LillyDirect, Mochi and NexLife, against Ro’s $448 to $598 a month for Zepbound (checked November 1, 2026).
  • Ro’s prices include its $149 monthly membership, or $74 a month if you prepay a year.
  • A first year of Zepbound through Ro is about $7,315 on its monthly membership, or $6,564 prepaid, on a typical dose ladder.
  • LillyDirect, no membership: Zepbound at $299 to $449 a month; $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699.
  • Insurance changes the math: if your plan covers Zepbound or Wegovy, your copay may beat any cash price, ours included.
  • At NexLife, compounded tirzepatide is $139 a month on the 12-month plan or $169 month to month; it isn’t FDA-approved.

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

By dose

How does Ro’s Zepbound price compare with LillyDirect’s?

At every dose, Ro’s monthly price is LillyDirect’s self-pay price plus $149, the cost of Ro’s monthly membership: $448 against $299 at 2.5 mg, $548 against $399 at 5 mg, and $598 against $449 from 7.5 mg (checked November 1, 2026). LillyDirect’s $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699. With your own prescriber, buying direct saves that $149 every month.

Zepbound’s monthly cash price by dose: Ro with its monthly membership, and LillyDirect for the medication alone, checked November 1, 2026.
DoseRo, membership includedLillyDirect, medication onlyDifference
2.5 mg$448$299$149
5 mg$548$399$149
7.5 mg and up$598$449$149

LillyDirect sells the medication only: you need your own prescriber, and a visit may cost extra. Ro’s price includes its membership, and Ro helps you check insurance coverage. LillyDirect’s $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699.

NexLife Price Match Guarantee†. Already on compounded tirzepatide or semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

Coverage

Is Ro worth it with insurance?

It can be. If your plan covers Zepbound or Wegovy, your copay may beat any cash price, ours included, and Ro’s help with coverage can be worth its $149 membership. Without coverage, you pay cash for both: $448 to $598 a month for Zepbound, membership included (checked November 1, 2026). That’s when the year above matters.

On Medicare Part D? The GLP-1 Bridge can bring Zepbound or Wegovy to $50 a month with prior authorization, for eligible enrollees.

Step by step

How do you check Ro’s real cost before you sign up?

Six steps, in order, using Ro’s and LillyDirect’s own prices, checked November 1, 2026.

  1. Check your coverage first. If your plan covers Zepbound or Wegovy, your copay may beat any cash price, ours included. On Medicare Part D, the GLP-1 Bridge can bring Zepbound or Wegovy to $50 a month, with prior authorization, for eligible enrollees.
  2. Price your dose, not the start. Ro’s Zepbound is $448 at 2.5 mg, $548 at 5 mg and $598 from 7.5 mg, membership included. Our first-year totals assume 7.5 mg or more from month 3.
  3. Add the membership. It’s $39 the first month, then $149 a month, or $74 a month if you prepay a year. Over a first year of Zepbound, the monthly membership adds $1,678.
  4. Count 13 fills, not 12. Zepbound comes in four-week fills, so a year holds 13. On a typical dose ladder, a first year through Ro is about $7,315, or $6,564 with the membership prepaid.
  5. Price Zepbound direct. LillyDirect sells Zepbound with no membership, at $299 to $449 a month by dose; $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699. Bring your own prescriber.
  6. Weigh compounded, knowing it’s different. Compounded tirzepatide isn’t FDA-approved, and a licensed provider prescribes it only when it offers a significant difference for you. At NexLife, it’s $139 a month on the 12-month plan or $169 month to month.

Six steps to Ro’s real cost: coverage, your dose, the membership, 13 fills, Zepbound direct and the compounded route.

Ro is built around insurance. We’re built around one price.

If Ro’s membership and brand-name prices don’t fit your budget, here is a steady alternative.

  • Coverage takes time. Prior authorizations and appeals can take weeks.
  • Memberships recur. Ro charges $149 a month on its monthly plan.
  • Brand-name prices climb. Zepbound through Ro runs $448 to $598 a month all in, by dose.

Not a coverage chase. A price you already know.

  • $139 a month on 12 months, at every dose. On a 12-month plan, or $169 month to month. No membership and no dose surcharge.
  • Care that answers. Real people 24/7, and physicians during clinical hours.
  • Named U.S. pharmacies. State-licensed 503A partner pharmacies: Absolute Pharmacy and Boudreaux’s New Drug Store.

Real people, no paperwork. No prior authorizations and no appeals, just a provider and a plan. Call or text (949) 818-8000, 24/7.
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.

Side by side

How does Ro compare with NexLife?

They sell different products. Ro prescribes brand-name Zepbound and Wegovy, which are FDA-approved; NexLife, compounded tirzepatide and semaglutide, which aren’t. Prices checked November 1, 2026.

Ro and NexLife side by side: medicine, price, dose pricing, membership, insurance, cancelling and pharmacies, from each one’s own pages, checked November 1, 2026
DetailRoNexLife
MedicineBrand-name Zepbound and Wegovy, pen and pill; FDA-approvedCompounded tirzepatide and semaglutide; not FDA-approved
PriceZepbound $448 to $598 a month, Wegovy $298 to $548, membership includedTirzepatide $139 a month on the 12-month plan or $169 month to month; semaglutide $119 on the 12-month plan or $139 month to month
Same price at every doseNo: Zepbound is $448 at 2.5 mg, $548 at 5 mg and $598 from 7.5 mgYes
Membership$39 for the first month, then $149 a month, or $74 a month if you prepay a yearNone
InsuranceHelps check your coverage; prior authorizations and appeals can take weeksNot needed, and no prior authorizations; pay by HSA or FSA card, Affirm, Klarna or Afterpay
CancellingNot covered in this guideBy email, effective 30 days after we receive it
Pharmacies namedNot covered in this guideTwo: Absolute Pharmacy and Boudreaux’s New Drug Store

NexLife Price Match Guarantee†. Already on compounded tirzepatide or semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

Alternatives

3 Ro weight loss alternatives, compared

We list our own plan first because NexLife publishes this guide; the other programs follow, with what each is best for.

NexLife

Our plan: a flat, all-in price

$139/mo on 12 monthsOn a 12-month plan; $169 month to month. Pay less elsewhere? Matched†

One of the most affordable, with no membership on top: $139 a month for compounded tirzepatide and $119 for semaglutide on 12-month plans ($169 and $139 month to month), at every dose. Your provider, a nutrition plan, a coaching call and round-the-clock support come with it. Compounded, so not FDA-approved.

LillyDirect

Best for brand-name without a membership

$299–$449

Zepbound at Lilly’s self-pay prices, $299 to $449 a month; $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699. Bring your own prescriber.

Mochi

Best for choosing your physician

$169 to start

Board-certified provider visits and a dietitian, with compounded and brand-name options. $169 to start, including a $79 membership; the medication costs more as your dose rises.

Best for

Which Ro alternative fits you?

Ro and the three alternatives on this page: what each suits, its price and its catch. Prices from each program’s own pages, checked November 1, 2026.

Ro and three alternatives: what each suits, its price and its catch, from each program’s own pages, checked November 1, 2026
Best forProgramPriceThe catch
One flat price at every dose, with no membershipNexLife (compounded)Tirzepatide $139 a month on the 12-month plan or $169 month to month; semaglutide $119 on the 12-month plan or $139 month to monthCompounded, so not FDA-approved; a licensed provider prescribes it only when it offers a significant difference for you
Brand-name Zepbound without a membershipLillyDirectZepbound $299 to $449 a month by dose; $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699Bring your own prescriber; a visit may cost extra
Choosing your physicianMochi$169 to start, including a $79 membershipThe medication costs more as your dose rises
Insurance that covers Zepbound or Wegovy, with help on the paperworkRoZepbound $448 to $598 and Wegovy $298 to $548 a month, its $149 membership includedPaying cash, a first year of Zepbound still costs $6,564 or more

Zepbound and Wegovy are FDA-approved; compounded tirzepatide and semaglutide aren’t. Prices checked November 1, 2026.

Fair is fair

When does Ro make sense?

When your insurance covers Zepbound or Wegovy and Ro handles the paperwork, when you want brand-name, FDA-approved medication only, or when you’ll prepay a year, which cuts its membership from $149 to $74 a month (checked November 1, 2026). Paying cash, a first year of Zepbound through Ro still costs $6,564 or more.

  • Your insurance covers Zepbound or Wegovy, and Ro handles the paperwork
  • You want brand-name, FDA-approved medication only
  • You’ll prepay a year, which cuts the membership to $74 a month

Switching

How do you switch from Ro?

Moving from brand-name Zepbound to compounded tirzepatide is a change of product (here’s how weight-loss injections online compare). A NexLife provider reviews your current dose and history and decides where you start. Keep taking your prescription until they confirm your next step.

One number while you leave Ro.

Call or text (949) 818-8000, any hour. A real person picks up, and we deal with the pharmacy so you don’t have to.

In their words

What do the FDA and CMS say about Zepbound doses, compounding and Medicare?

Three primary-source lines behind this page: how a Zepbound dose climbs, when compounded medicine fits, and the Medicare Bridge copay.

Ro’s Zepbound price rises with the dose, from $448 at 2.5 mg, and the FDA’s approval notice describes how the dose climbs.

“Zepbound is administered by injection under the skin once weekly, and the dosage must be increased over four to 20 weeks to achieve the target dosages of 5 milligram (mg), 10 mg or 15 mg once weekly. The maximum dosage of Zepbound is 15 mg once weekly.”

U.S. Food and Drug Administration, FDA Approves New Medication for Chronic Weight Management

Ro prescribes FDA-approved Zepbound and Wegovy, so a compounded alternative is a change of product; the FDA says when compounded medicine fits.

“Compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.”

U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

On Medicare Part D, check the GLP-1 Bridge before you pay Ro’s cash price; CMS puts the copay simply.

“Eligible beneficiaries will have a $50 copay.”

Centers for Medicare & Medicaid Services, Medicare GLP-1 Bridge, FAQs

Vial math

How many units is your tirzepatide or semaglutide dose?

On a compounded vial, the units depend on its strength. Here are the label doses at example strengths, with the math to check your own.

Tirzepatide

Tirzepatide doses on Zepbound’s label, with the volume and units on a U-100 syringe at an example strength of 25 mg per mL; your vial’s label decides
DosemL at 25 mg/mLUnits (U-100)On the label
2.5 mg0.1 mL10 unitsStarting dose, for 4 weeks
5 mg0.2 mL20 unitsA maintenance dose
7.5 mg0.3 mL30 unitsA step up
10 mg0.4 mL40 unitsA maintenance dose
12.5 mg0.5 mL50 unitsA step up
15 mg0.6 mL60 unitsThe maximum, and a maintenance dose

The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.

Semaglutide

Semaglutide dose steps from the Wegovy label, with the volume and units on a U-100 syringe at two example strengths, 2.5 mg/mL and 5 mg/mL
WeeksWeekly doseAt 2.5 mg/mLAt 5 mg/mL
1 to 40.25 mg0.1 mL (10 units)0.05 mL (5 units)
5 to 80.5 mg0.2 mL (20 units)0.1 mL (10 units)
9 to 121 mg0.4 mL (40 units)0.2 mL (20 units)
13 to 161.7 mg0.68 mL (68 units)0.34 mL (34 units)
17 onward2.4 mg0.96 mL (96 units)0.48 mL (48 units)

The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 2.5 mg/mL, 1 mg is 1 ÷ 2.5 = 0.4 mL, or 40 units. At 5 mg/mL, the same 1 mg is 0.2 mL, or 20 units.

25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart. Both strengths are examples only. The same dose is a different number of units at a different strength, so read the strength on your own vial’s label. Your prescription sets your dose and schedule, which may differ from these label steps. Every step: the semaglutide dosage chart.

What would you pay with NexLife?

Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.

Pick one above to see your price.

Check my eligibility
Not today?

Prices from each provider’s own site, checked November 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $139/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $119/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan; $139/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

Ro alternatives: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

How much does Ro weight loss cost?

Ro’s prices include its $149 monthly membership: brand-name Zepbound is $448 to $598 a month and Wegovy $298 to $548, rising with your dose (checked November 1, 2026). Prepaying a year cuts the membership to $74 a month. On a typical dose ladder, a first year of Zepbound comes to about $7,315 on the monthly membership.

How much is Ro tirzepatide?

Ro prescribes brand-name Zepbound at $448 to $598 a month, its $149 monthly membership included: $448 at 2.5 mg, $548 at 5 mg and $598 from 7.5 mg on the monthly plan (checked November 1, 2026). Its pricing page lists no compounded tirzepatide.

Does Ro charge a membership fee?

Yes: $149 a month on the monthly plan, after a $39 first month, or $74 a month if you prepay a year (checked November 1, 2026). Ro’s Zepbound and Wegovy prices include it. Over a first year of Zepbound, the monthly membership adds $1,678. NexLife has no membership fee.

Does Ro offer compounded tirzepatide?

Not on its pricing page, which lists brand-name Zepbound and Wegovy (checked November 1, 2026). Zepbound is FDA-approved; compounded tirzepatide isn’t. For compounded tirzepatide, NexLife charges $139 a month on the 12-month plan or $169 month to month, with no membership fee and no change with your dose.

What’s cheaper than Ro for Zepbound?

LillyDirect’s Zepbound, no membership: $299 to $449 a month by dose (checked November 1, 2026); bring your own prescriber. Its $449 (7.5 to 15 mg) needs a refill within 45 days; otherwise, $499 to $699. NexLife doesn’t sell Zepbound. Compounded tirzepatide, a different product, not FDA-approved, is $139 a month on its 12-month plan or $169 month to month.

What’s a cheaper alternative to Ro?

Compounded tirzepatide costs less in cash: $139 to $399 a month across the 14 programs in our GLP-1 price index (median $237), against $448 to $598 for Zepbound through Ro (checked November 1, 2026). At NexLife, it’s $139 a month on the 12-month plan or $169 month to month, at every dose. Pay less elsewhere? We match it.†

Can I switch from Ro to NexLife?

Yes, after a provider’s review. Zepbound and compounded tirzepatide are different products, so your NexLife provider looks at the dose you’re on and your history, then sets your starting dose. Stay on your Zepbound until then. Real people answer 24/7 at (949) 818-8000. Here’s how switching GLP-1 providers works.

Is Ro worth it?

It can be if your insurance covers Zepbound or Wegovy: your copay may beat any cash price, and Ro’s help with coverage can be worth its $149 monthly membership. Paying cash, a first year of Zepbound through Ro costs $6,564 or more, against $5,637 at LillyDirect with no membership (checked November 1, 2026).

Can Medicare lower the cost of Zepbound or Wegovy?

Yes, if you’re eligible: on Medicare Part D, the GLP-1 Bridge can bring Zepbound or Wegovy to $50 a month with prior authorization. Check it before you pay Ro’s cash price, which is $448 to $598 a month for Zepbound, membership included (checked November 1, 2026).

Why does Zepbound cost more through Ro than LillyDirect?

It’s Ro’s membership: at every dose, Ro charges LillyDirect’s self-pay price plus $149, so $448 against $299 at 2.5 mg, $548 against $399 at 5 mg and $598 against $449 from 7.5 mg, where LillyDirect’s $449 needs a refill within 45 days. Buying direct with your own prescriber saves that $149.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

“No. A generic drug is approved by FDA under 505(j) of the FD&C Act and meets all of the requirements of that section (including establishing therapeutic equivalence to a brand name drug, among others), while a compounded drug is not approved by FDA.”

U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Ro’s published prices and membership, LillyDirect’s self-pay prices and the alternatives’ prices; first-year totals calculated from them

  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.

Paying less elsewhere? We match it.†

One price for the whole year.

Start online in about 3 minutes. A licensed provider decides if treatment is right for you.

4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Ro. Weight loss pricing.
  2. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
  3. KFF. What to know about the BALANCE Model and the Medicare GLP-1 Bridge (updated May 11, 2026).
  4. Mochi. FAQs and pricing.
  5. NexLife. Compounded tirzepatide plans.
  6. NexLife. Compounded semaglutide plans.
  7. U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
  8. Novo Nordisk. Wegovy (semaglutide) prescribing information.
  9. LegitScript. LegitScript certification record for NexLife.us.
  10. Ro: weight loss program pricing. Checked November 1, 2026.
  11. Hims: Zepbound KwikPen. Checked November 1, 2026.
  12. Hims: Wegovy pill and pen, with membership. Checked November 1, 2026.
  13. Mochi Health: FAQs (membership and medication prices). Checked November 1, 2026.
  14. Embody: compounded tirzepatide, one-month supply. Checked November 1, 2026.
  15. Embody: compounded semaglutide, one-month supply. Checked November 1, 2026.
  16. Eli Lilly and Company. Authentic Zepbound® (tirzepatide) Shipped to You | LillyDirect®. Self-pay prices by dose. Checked November 2, 2026.
  17. Eli Lilly and Company. Zepbound® (tirzepatide): Full Terms and Conditions. The 45-day refill condition and regular prices. Read November 2, 2026.
  18. Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. Read November 2, 2026.
  19. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Read November 2, 2026.
  20. U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management.